Trends in prevalence from 1990 to 2007 of patients hospitalized with heart failure in Sweden

Parén, Pär; Schaufelberger, Maria; Björck, Lena; Lappas, Georgios; Fu, Michael; Rosengren, Annika

doi:10.1002/ejhf.109

Cited by 57 publications

(71 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…During the first decade of the 21st century, declining trends of HF hospitalizations were reported in the USA, Australia, England, Ireland, New Zealand, and Canada, or unchanged . Increasing numbers of HF hospitalizations, however, were observed in the Netherlands, Italy, Spain, and Germany ( Figure , Table ).…”

Section: Discussionmentioning

confidence: 99%

Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System

Christ

Störk

Dörr

et al. 2016

European J of Heart Fail

118

View full text Add to dashboard Cite

Aims Considerable differences in the long‐term trends of heart failure (HF) exist between different countries. To extend the existing knowledge on HF epidemiology in Germany, we analysed trends of HF‐related hospitalizations, hospital days and in‐hospital deaths during a 14‐year period (2000–2013). Methods and results Data were derived from the official German Federal Health Monitoring System, which includes an annual and complete enumeration of inpatients at the time of discharge from the hospital. HF cases were identified by the primary diagnosis code for HF (I50). From 2000 to 2013, the absolute number of HF‐related hospitalizations increased by 65.4% (239 694–396 380 cases) and by 28.4% after age‐standardization (261–335 per 100 000 population). Accordingly, the absolute number of HF‐related hospital days increased by 22.1% (3.4–4.2 million hospital days), despite a marked decrease by 25.9% in average length of stay (14.3–10.6 days). With approximately 35 000 in‐hospital deaths (∼45 per 100 000 population), the annual number of HF‐related in‐hospital deaths remained consistently high, and in‐hospital mortality rate in HF patients constituted 9.3% in 2013. Patients aged >65 years were disproportionately affected. In 2013, HF was the leading cause of disease‐related hospitalizations and in‐hospital deaths, representing 2.1% and 8.8% of all cases, respectively. Conclusion In Germany, the burden of HF is growing further, and the risk of death in HF remains high. These trends can only be partly attributed to demographic developments suggesting an exigent need for increased awareness and enhanced efforts in the prevention and management of HF.

show abstract

Section: Discussionmentioning

confidence: 99%

Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System

Christ

Störk

Dörr

et al. 2016

European J of Heart Fail

118

View full text Add to dashboard Cite

show abstract

“…initial increase followed by decline). Total HF event rates declined in the US (2006–2014), Western Australia (1990–2005), Sweden (2002–2007) and France (2000–2012) but increased from 2003 up to 2007 and then flattened through 2013 in Spain …”

Section: Discussionmentioning

confidence: 99%

Heart failure in Norway, 2000–2014: analysing incident, total and readmission rates using data from the Cardiovascular Disease in Norway (CVDNOR) Project

Sulo

Igland

Øverland

et al. 2019

European J of Heart Fail

View full text Add to dashboard Cite

Aims To examine trends in heart failure (HF) hospitalization rates and risk of readmissions following an incident HF hospitalization. Methods and results During 2000–2014, we identified in the Cardiovascular Disease in Norway Project 142 109 hospitalizations with HF as primary diagnosis. Trends of incident and total (incident and recurrent) HF hospitalization rates were analysed using negative binomial regression models. Changes over time in 30‐day and 3‐year risk of HF recurrences or cardiovascular disease (CVD)‐related readmissions were analysed using Fine and Grey competing risk regression, with death as competing events. Age‐standardized rates declined on average 1.9% per year in men and 1.8% per year in women for incident HF hospitalizations (both Ptrend < 0.001) but did not change significantly in either men or women for total HF hospitalizations. In men surviving the incident HF hospitalization, 30‐day and 3‐year risk of a HF recurrent event increased 1.7% and 1.2% per year, respectively. Similarly, 30‐day and 3‐year risk of a CVD‐related hospitalization increased 1.5% and 1.0% per year, respectively (all Ptrend < 0.001). No statistically significant changes in the risk of HF recurrences or CVD‐related readmissions were observed among women. In‐hospital mortality for a first and recurrent HF episode declined over time in both men and women. Conclusions Incident HF hospitalization rates declined in Norway during 2000–2014. An increase in the risk of recurrences in the context of reduced in‐hospital mortality following an incident and recurrent HF hospitalization led to flat trends of total HF hospitalization rates.

show abstract

“…Heart failure (HF) is a common and serious disorder with a prevalence of approximately 2% in the Swedish population. Although the total age‐adjusted incidence of HF in Sweden has decreased since 1993, there has been an increase among younger individuals . HF is costly, and treatment is estimated to consume 5.0–6.7 billion Swedish krona (SEK) per annum, of which half is spent on in‐hospital and nursing home care …”

Section: Introductionmentioning

confidence: 99%

Validity of heart failure diagnoses made in 2000–2012 in western Sweden

et al. 2019

Self Cite

View full text Add to dashboard Cite

Aims The aim of this study is to validate a diagnosis of heart failure (HF) according to the European Society of Cardiology (ESC) guidelines among patients hospitalized at Sahlgrenska University Hospital, Gothenburg, Sweden, between 2000 and 2012. Methods and results In Sweden, it is mandatory to report all hospital discharge diagnoses to the Swedish national inpatient register. In total, 27 517 patients were diagnosed with HF at the Sahlgrenska University hospital between 2000 and 2012. Altogether, 1100 records with a primary (n = 550) or contributory (n = 550) diagnosis of HF were randomly selected. The diagnosis was validated according to the ESC guidelines from 1995, 2001, 2005, and 2008, and cases were divided into three groups: definite, probable, and miscoded. In total, 965 cases were validated, while 135 records were excluded for various reasons. Of the 965 records, the diagnosis was validated as definite in 601 (62.3%) and as probable in 310 (32.1%); only 54 (5.6%) of cases had been miscoded. Echocardiography, as an objective evidence of cardiac dysfunction, had been performed in 581 (96.7%) of the definite, 106 (34.2%) of the probable, and 31 (57.4%) of the miscoded cases. Among the probable cases, the main reason they had not been classified as a definitive diagnosis of HF was lack of examination by echocardiography (63.8%). Conclusions The overall validity of HF diagnosis at Sahlgrenska University Hospital is high. This may reflect a high diagnostic validity at the time of diagnosis in the national Swedish patient register, supporting the continued use of this register in epidemiological research.

show abstract

Trends in prevalence from 1990 to 2007 of patients hospitalized with heart failure in Sweden

Cited by 57 publications

References 29 publications

Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System

Heart failure epidemiology 2000–2013: insights from the German Federal Health Monitoring System

Heart failure in Norway, 2000–2014: analysing incident, total and readmission rates using data from the Cardiovascular Disease in Norway (CVDNOR) Project

Validity of heart failure diagnoses made in 2000–2012 in western Sweden

Contact Info

Product

Resources

About